Accendra Health (FRA:6OM) Beta: 0.1844 (As of Jun. 25, 2026)


FRA:6OM Accendra Health Inc FRA:6OM
57 GF Score
Price €2.72
GF Value €4.27
! 7 Warning Signs
View Full Analysis

What is Accendra Health Beta?

Accendra Health FRA:6OM +2.26% 57 Beta is 0.1844 as of Jun. 25, 2026. GuruFocus rates FRA:6OM with a GF Score™ of 57/100 and a GF Value™ of €4.27. The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Accendra Health's Beta is 0.1844.


Accendra Health  (FRA:6OM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Accendra Health Beta Related Terms


Accendra Health Beta Historical Data

* Premium members only.

The historical data trend for Accendra Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Beta Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.20 -0.79 0.64 0.10 1.35

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.17 -0.66 1.35 -1.05

FRA:6OM vs EDAP, YI, COSM: Beta Comparison

For the Medical Distribution subindustry, Accendra Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health Beta vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Beta distribution charts can be found below:

* The bar in red indicates where Accendra Health's Beta falls into.


FRA:6OM
57GF Score
Accendra Health Inc FRA:6OM
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1844 mean?
Accendra Health (FRA:6OM) has a Beta of 0.1844 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Accendra Health and its competitors.
Is Accendra Health's Beta too high?
Accendra Health's current Beta is 0.1844. Overall, Accendra Health has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Beta compare to EDAP and YI?
Accendra Health's Beta of 0.1844 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Distribution company?
A good Beta depends on the Medical Distribution industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Accendra Health and its competitors. Accendra Health's current Beta is 0.1844. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Accendra Health (FRA:6OM) has a current Beta of 0.1844. The stock's GF Value™ is €4.27, compared to a current price of €2.72 — trading 36.3% below its estimated fair value. The current Beta is 0.1844. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Accendra Health (FRA:6OM), the current Beta is 0.1844 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (FRA:6OM) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of €2.72 is trading 36.3% below its estimated GF Value™ of €4.27.

Key valuation signals for FRA:6OM:

  • Beta: 0.1844
  • GF Value™: €4.27 vs. price of €2.72 (36.3% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the FRA:6OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges ACH:USA6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score

Get the complete analysis for FRA:6OM

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.72
Price
€4.27
GF Value